325 related articles for article (PubMed ID: 26880182)
1. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
[TBL] [Abstract][Full Text] [Related]
2. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
5. Zinc supplements for treating thalassaemia and sickle cell disease.
Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation for sickle cell disease.
Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
12. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
Asnani MR; Quimby KR; Bennett NR; Francis DK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
Aboursheid T; Albaroudi O; Alahdab F
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD011808. PubMed ID: 31603241
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
Aboursheid T; Albaroudi O; Alahdab F
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
[TBL] [Abstract][Full Text] [Related]
15. Fortification of wheat and maize flour with folic acid for population health outcomes.
Centeno Tablante E; Pachón H; Guetterman HM; Finkelstein JL
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012150. PubMed ID: 31257574
[TBL] [Abstract][Full Text] [Related]
16. Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.
Suchdev PS; Peña-Rosas JP; De-Regil LM
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011158. PubMed ID: 26091836
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
[TBL] [Abstract][Full Text] [Related]
18. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Fortin PM; Trivella M; Hopewell S
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003149. PubMed ID: 27049331
[TBL] [Abstract][Full Text] [Related]
19. Intermittent oral iron supplementation during pregnancy.
Peña-Rosas JP; De-Regil LM; Gomez Malave H; Flores-Urrutia MC; Dowswell T
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009997. PubMed ID: 26482110
[TBL] [Abstract][Full Text] [Related]
20. Treatment for osteoporosis in people with beta-thalassaemia.
Bhardwaj A; Swe KMM; Sinha NK
Cochrane Database Syst Rev; 2023 May; 5(5):CD010429. PubMed ID: 37159055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
